Complete financial analysis of Regis Healthcare Limited (REG.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Regis Healthcare Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Zodiac-JRD-MKJ Limited (ZODJRDMKJ.NS) Income Statement Analysis – Financial Results
- Trine II Acquisition Corp. (TRAQ-UN) Income Statement Analysis – Financial Results
- BeyondSpring Inc. (BYSI) Income Statement Analysis – Financial Results
- Regen BioPharma, Inc. (RGBP) Income Statement Analysis – Financial Results
- First Au Limited (FAU.AX) Income Statement Analysis – Financial Results
Regis Healthcare Limited (REG.AX)
About Regis Healthcare Limited
Regis Healthcare Limited provides residential aged care services in Australia. The company offers home care services, including personal hygiene and care, dressing and undressing, mobility and transportation, rehabilitation, and others; and home help services, such as cleaning, cooking, shopping, transportation, and facilitating social outings. It also provides companionship, and government-funded and private home care services; and owns and operates specialist retirement and independent living villages, which offers laundry, meals, and cleaning, as well as allied health services comprising physiotherapy, podiatry, diversional therapy, and therapeutic activities. In addition, the company provides aged care services, including ageing-in-place, respite care, dementia care, and palliative care services; in-home disability support and veterans' home care services; and therapeutic services to people living in the community, in retirement villages, and low care homes, as well as operates Day Respite centres. As of June 30, 2022, it owned and operated 64 residential aged care homes. The company was formerly known as Fairway Investment Holdings Pty Ltd. and changed its name to Regis Healthcare Limited in 2014. Regis Healthcare Limited was founded in 1994 and is based in Armadale, Australia.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.01B | 771.48M | 717.90M | 685.87M | 666.15M | 646.86M | 594.40M | 565.48M | 480.75M | 437.51M | 409.54M | 353.60M |
Cost of Revenue | 838.80M | 775.26M | 712.72M | 618.33M | 585.27M | 485.75M | 432.34M | 398.26M | 340.55M | 304.76M | 238.13M | 211.70M |
Gross Profit | 175.25M | -3.78M | 5.18M | 67.54M | 80.89M | 161.11M | 162.06M | 167.22M | 140.20M | 132.75M | 171.41M | 141.91M |
Gross Profit Ratio | 17.28% | -0.49% | 0.72% | 9.85% | 12.14% | 24.91% | 27.26% | 29.57% | 29.16% | 30.34% | 41.85% | 40.13% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 37.56M | 58.64M | 42.62M | 39.55M | 38.28M | 32.81M | 27.64M | 26.06M | 21.43M | 23.45M | 9.34M | 7.68M |
Selling & Marketing | 42.91M | 13.94M | -1.34M | 11.58M | 16.95M | 20.76M | 18.01M | 16.59M | 12.84M | 1.43M | 1.18M | 1.56M |
SG&A | 80.47M | 72.59M | 41.28M | 51.13M | 55.22M | 53.57M | 45.65M | 42.64M | 34.28M | 35.20M | 53.67M | 47.06M |
Other Expenses | 0.00 | 665.91M | 589.47M | 582.89M | 533.28M | 461.53M | 422.35M | 406.49M | 335.06M | 334.59M | 0.00 | 0.00 |
Operating Expenses | 80.47M | 72.59M | 41.28M | 51.13M | 55.22M | 79.76M | 77.09M | 73.60M | 69.16M | 46.63M | 125.24M | 101.20M |
Cost & Expenses | 919.28M | 847.85M | 754.00M | 669.46M | 640.49M | 565.51M | 509.42M | 471.86M | 409.71M | 351.38M | 363.37M | 312.90M |
Interest Income | 3.98M | 705.00K | 9.00K | 14.00K | 45.00K | 11.72M | 8.20M | 5.90M | 954.00K | 8.04M | 20.55M | 16.46M |
Interest Expense | 91.65M | 12.45M | 9.40M | 10.48M | 13.46M | 17.53M | 16.04M | 10.75M | 4.92M | 15.09M | 0.00 | 16.46M |
Depreciation & Amortization | 128.08M | 126.46M | 103.11M | 43.89M | 44.07M | 33.93M | 27.58M | 29.51M | 21.85M | 18.91M | 17.34M | 21.25M |
EBITDA | 191.45M | 96.81M | 55.86M | 82.65M | 61.55M | 107.54M | 116.42M | 124.58M | 93.79M | 97.55M | 62.75M | 63.99M |
EBITDA Ratio | 18.88% | 6.49% | 9.33% | 8.79% | 10.47% | 16.62% | 19.59% | 22.03% | 22.03% | 22.30% | 15.32% | 18.10% |
Operating Income | 94.78M | -76.37M | -36.10M | 16.41M | 25.66M | 73.61M | 88.83M | 95.07M | 84.06M | 78.64M | 45.41M | 42.74M |
Operating Income Ratio | 9.35% | -9.90% | -5.03% | 2.39% | 3.85% | 11.38% | 14.95% | 16.81% | 17.49% | 17.97% | 11.09% | 12.09% |
Total Other Income/Expenses | -122.88M | -96.95M | -104.77M | -34.85M | -19.95M | -37.91M | -7.06M | -36.86M | -13.98M | -19.46M | -23.68M | -18.49M |
Income Before Tax | -28.10M | -40.38M | -55.19M | 29.15M | 5.72M | 69.63M | 76.77M | 87.72M | 70.08M | 78.09M | 25.63M | 24.25M |
Income Before Tax Ratio | -2.77% | -5.23% | -7.69% | 4.25% | 0.86% | 10.76% | 12.92% | 15.51% | 14.58% | 17.85% | 6.26% | 6.86% |
Income Tax Expense | -6.69M | -11.93M | -16.39M | 9.20M | 6.43M | 18.73M | 22.90M | 26.62M | 23.55M | 20.57M | 24.58M | 7.16M |
Net Income | -21.42M | -28.45M | -38.80M | 19.95M | -716.00K | 50.90M | 53.87M | 61.10M | 46.07M | 57.51M | 1.05M | 17.09M |
Net Income Ratio | -2.11% | -3.69% | -5.40% | 2.91% | -0.11% | 7.87% | 9.06% | 10.81% | 9.58% | 13.15% | 0.26% | 4.83% |
EPS | -0.07 | -0.09 | -0.13 | 0.07 | 0.00 | 0.17 | 0.18 | 0.20 | 0.15 | 0.21 | 0.00 | 0.05 |
EPS Diluted | -0.07 | -0.09 | -0.13 | 0.07 | 0.00 | 0.17 | 0.18 | 0.20 | 0.15 | 0.21 | 0.00 | 0.05 |
Weighted Avg Shares Out | 301.04M | 300.89M | 300.82M | 300.77M | 300.73M | 300.63M | 300.49M | 300.36M | 300.35M | 271.84M | 300.35M | 351.44M |
Weighted Avg Shares Out (Dil) | 301.04M | 300.89M | 300.82M | 300.86M | 300.79M | 300.91M | 300.72M | 300.75M | 300.54M | 271.94M | 300.35M | 351.44M |
Source: https://incomestatements.info
Category: Stock Reports